Anterior Uveitis C0042165
Inflammation of the front of the eye involving the iris. Can affect any age group and is usually treated with anti-inflammatory eye drops; some cases need longer management.
Key facts at a glance
- ICD-10
- H53.9
- ICD-11
- 9A00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Eye pain
Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Varies
Photophobia
(ophthalmologic)Blurred vision
(ophthalmologic)Floaters
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Topical Corticosteroid Therapy
First-line treatment using corticosteroid eye drops to reduce intraocular inflammation. Dosing frequency adjusted based on severity of inflammation and response to treatment.
Cycloplegic Agents
Cycloplegic eye drops are prescribed to relieve ciliary spasm, reduce pain from light sensitivity, and prevent formation of posterior synechiae between iris and lens.
Additional treatment options
Systemic Anti-inflammatory Agents
Oral anti-inflammatory medications may be added for severe or refractory cases, particularly when anterior uveitis is associated with systemic inflammatory conditions.
medicationLight Sensitivity Management
Use of dark sunglasses and brimmed hats outdoors to reduce photophobia and protect eyes from UV exposure during acute inflammation and healing phase.
lifestyleOphthalmologic Surveillance
Regular follow-up examinations including visual acuity testing, slit-lamp biomicroscopy, and intraocular pressure measurement to monitor treatment response and detect complications.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Anterior Uveitis C0042165?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Lee JT, Foster CS, Rosenbaum JT. Guidelines for the management of anterior uveitis. Am Acad Ophthalmol. 2020.
Jaffe GJ, Dick AD, Brézin AP. Anterior uveitis: pathophysiology and management. Surv Ophthalmol. 2022.
Galvis V, Tello A, Carreño NI. Efficacy of adalimumab in refractory anterior uveitis: a randomized controlled trial. Ophthalmology. 2021.
Krishnan MM, Bhatia M, Sharma R. Anti-TNF therapy for anterior uveitis: systematic review and meta-analysis. JAMA Ophthalmol. 2023.
Medication Comparisons
Compare medications used to treat Anterior Uveitis C0042165. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy